-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On Orchestra BioMed Hldgs with Buy Rating, Announces Price Target of $15

Benzinga·12/10/2025 16:03:00
語音播報
TD Cowen analyst Joshua Jennings initiates coverage on Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy rating and announces Price Target of $15.